Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies.

Dayan CM, Lecumberri B, Muller I, Ganesananthan S, Hunter SF, Selmaj KW, Hartung HP, Havrdova EK, LaGanke CC, Ziemssen T, Van Wijmeersch B, Meuth SG, Margolin DH, Poole EM, Baker DP, Senior PA

Open source

DOI: 10.1177/20552173221142741
Published: 2023 Jan-Mar
Container: Multiple sclerosis journal - experimental, translational and clinical
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/20552173221142741,
  title = {Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies.},
  author = {Dayan CM and Lecumberri B and Muller I and Ganesananthan S and Hunter SF and Selmaj KW and Hartung HP and Havrdova EK and LaGanke CC and Ziemssen T and Van Wijmeersch B and Meuth SG and Margolin DH and Poole EM and Baker DP and Senior PA},
  year = {2023},
  journal = {Multiple sclerosis journal - experimental, translational and clinical},
  doi = {10.1177/20552173221142741},
  url = {https://doi.org/10.1177/20552173221142741}
}

RIS

TY  - JOUR
TI  - Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies.
AU  - Dayan CM
AU  - Lecumberri B
AU  - Muller I
AU  - Ganesananthan S
AU  - Hunter SF
AU  - Selmaj KW
AU  - Hartung HP
AU  - Havrdova EK
AU  - LaGanke CC
AU  - Ziemssen T
AU  - Van Wijmeersch B
AU  - Meuth SG
AU  - Margolin DH
AU  - Poole EM
AU  - Baker DP
AU  - Senior PA
PY  - 2023
JO  - Multiple sclerosis journal - experimental, translational and clinical
DO  - 10.1177/20552173221142741
UR  - https://doi.org/10.1177/20552173221142741
ER  -

APA

CM, D., B, L., I, M., S, G., SF, H., KW, S., HP, H., EK, H., CC, L., T, Z., B, V. W., SG, M., DH, M., EM, P., DP, B., & PA, S. (2023). Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies.. Multiple sclerosis journal - experimental, translational and clinical. https://doi.org/10.1177/20552173221142741

Source records

pubmed · retrieved 2026-09-26T17:58:58.265Z